Bouma G J, van Caubergh P, van Bree S P, Castelli-Visser R M, Witvliet M D, van der Meer-Prins E M, van Rood J J, Claas F H
Department of Immunohematology, Leiden University Hospital, The Netherlands.
Transplantation. 1996 Sep 15;62(5):672-8. doi: 10.1097/00007890-199609150-00023.
Some transplant centers consider paternal HLA antigens as unacceptable mismatches for mothers awaiting kidney transplantation. It is feared that a pregnancy may cause priming of the maternal immune response directed toward paternal HLA antigens. Should a woman receive an organ from a donor who shares those paternal HLA antigens, the risk of graft rejection might be increased. It is known that some women, as a consequence of pregnancy, develop antibodies specific for paternal HLA antigens. The purpose of the present study was to investigate whether a pregnancy can also prime the cellular immune response and whether this occurs in all cases. Frequencies of maternal cytotoxic T lymphocytes directed to paternal HLA antigens were evaluated in limiting dilution analysis assays and compared with those directed to third-party HLA antigens. Differentiation between naive and in vivo primed cytotoxic T lymphocytes was made by performing these assays in the absence and presence of anti-CD8, respectively. No difference in the frequency nor sensitivity to blocking by anti-CD8 was found when maternal cytotoxic T lymphocytes directed toward paternal HLA antigens were compared with those against third-party HLA antigens. However, more heterogeneous responses were detected against paternal HLA antigens. Therefore, paternal antigens that had been inherited by children were analyzed separately from the paternal antigens that had not been inherited. Furthermore, the presence of pregnancy-induced HLA antibodies was taken into consideration. Naive cytotoxic T lymphocyte responses were detected against paternal antigens that had never been inherited and those that had been inherited but had not induced antibody formation. In contrast, inherited paternal antigens that had induced HLA-specific antibodies in the mother gave rise to elevated cytotoxic T lymphocyte precursor frequencies, as compared with the response to third-party antigens. Also, the cytotoxic T lymphocytes were found to be more resistant to inhibition by anti-CD8, suggesting that these cells had been primed in vivo. These results suggest that not all paternal HLA antigens have to be considered as unacceptable mismatches. Only those individuals who share a paternal HLA antigen against which a mother has formed HLA-specific alloantibodies should be excluded from organ donation.
一些移植中心认为,对于等待肾移植的母亲来说,父系HLA抗原属于不可接受的错配。人们担心怀孕可能会引发母体针对父系HLA抗原的免疫反应。如果一名女性接受来自具有那些父系HLA抗原供体的器官,移植排斥的风险可能会增加。已知一些女性由于怀孕会产生针对父系HLA抗原的特异性抗体。本研究的目的是调查怀孕是否也会引发细胞免疫反应以及这种情况是否在所有病例中都会发生。在有限稀释分析试验中评估了母体针对父系HLA抗原的细胞毒性T淋巴细胞频率,并与针对第三方HLA抗原的细胞毒性T淋巴细胞频率进行比较。分别在不存在和存在抗CD8的情况下进行这些试验,以区分初始细胞毒性T淋巴细胞和体内致敏的细胞毒性T淋巴细胞。当将母体针对父系HLA抗原的细胞毒性T淋巴细胞与针对第三方HLA抗原的细胞毒性T淋巴细胞进行比较时,发现频率和对抗CD8阻断的敏感性均无差异。然而,检测到针对父系HLA抗原的反应更具异质性。因此,将子女继承的父系抗原与未被继承的父系抗原分开进行分析。此外,还考虑了怀孕诱导的HLA抗体的存在。检测到针对从未被继承的父系抗原以及已被继承但未诱导抗体形成的父系抗原的初始细胞毒性T淋巴细胞反应。相比之下,与对第三方抗原的反应相比,在母亲体内诱导了HLA特异性抗体的已继承父系抗原会导致细胞毒性T淋巴细胞前体频率升高。此外,还发现细胞毒性T淋巴细胞对抗CD8抑制的抵抗力更强,这表明这些细胞已在体内被致敏。这些结果表明,并非所有父系HLA抗原都应被视为不可接受的错配。只有那些具有母亲已形成HLA特异性同种抗体的父系HLA抗原的个体才应被排除在器官捐赠之外。